{
    "2018-08-15": [
        [
            {
                "time": "2023-10-17",
                "original_text": "Novo Nordisk’s Biopharmaceuticals Segment: An Update",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Biopharmaceuticals",
                        "Segment",
                        "Update"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-17",
                "original_text": "Analysts’ Recommendations for GlaxoSmithKline Stock",
                "features": {
                    "keywords": [
                        "Analysts",
                        "Recommendations",
                        "GlaxoSmithKline",
                        "Stock"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}